MICROBES AND MAN Research Programme 2003-2005 October 13, 2004 Berlin Soile Juuti Programme manager Finland.

Slides:



Advertisements
Similar presentations
MICMAN Final Symposium 2006 MICROBES AND MAN Research Programme
Advertisements

Hungarian GEnomic Research on pathogenic Microbes Hu-GERM.
Research Programme on Nutrition Food and Health ELVIRA ( ) “Novel high-quality and innovative research that in the long run helps consumers.
Immunity to Infectious Diseases BIOS 486A/586A K.J.Goodrum 2006.
Bacterial Physiology (Micr430) Lecture 18 Bacterial Pathogenesis (Based on other textbooks such as Madigan’s)
General Microbiology (Micr300)
Sisältö Chapter 1: The History and Scope of Microbiology
Hannover Medical School February 15 th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Development of new tools to study the cell biology and origins of phenotypic variation in the human pathogen Streptococcus pneumoniae: An overview of recently.
BIO 411 – Medical Microbiology Chapter 9 Commensal and Pathogenic Microbial Flora.
Sequencing capacitiesacademic company based microarray facilitiesacademic company based bioinformaticsacademic proteomic facilitiesacedemic Genome Research.
ERA-NET PathoGenoMics Meeting Bonn 7-8 April, 2005 Research topics of interest in the Area of Genomics of Bacterial and Fungal Pathogens of Humans Prof.
Infection & Disease Unit 5. Stages of clinical infections 1. incubation period time from initial contact to first signs of symptoms 2. prodrome period.
12/09/ Introduction to the Research Programmes of the Academy of Finland Sirpa Nuotio Programme Manager.
Infections of the GI Tract November 19, 2007 NCDD Meeting Chair: Mitchell B. Cohen, MD Vice Chair: Richard S. Blumberg, MD.
Host-Microbe Interactions Chapter 14. Disease Etiology Pathogen –Primary vs. opportunistic Virulence.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
You have more bacterial cells in or on your body than you have human cells. These microorganisms are the “normal humans flora” and are important to the.
WP3 Strategic analysis of the future perspectives for cooperation and coordination Summary of the expert workshop on the European Research Agenda (WP 3)
460 MIC ( MEDICAL BACTERIOLOGY ) 3(1+2) / الشعبة ( ) د / أمل بنت عبد العزيز الهزاني 542/7/1.
Microbial Interactions with Humans Basic Definitions Ecological Interactions Normal Microbiota Infectious Diseases Disease = any change in state of health.
Genetic Screenings for Studying Bacterial Pathogenesis Dongwoo Shin, Ph.D. Associate Professor, Department of Molecular Cell Biology, Sungkyunkwan University.
Ministry of Education, Science and Sport Republic of Slovenia Ministry of Education, Science and Sport Republic of Slovenia Research in Slovenia Dr. Livija.
Helicobacter pylori Vaccine Development Catherine O. Johnson March 9, 2006.
January 30, 2003 MICMAN MICROBES AND MAN Research Programme Soile Juuti Programme manager.
Nature of Disease Introduction - Definitions Normal Bacteria & Host Koch’s Postulates Patterns of Disease Spread of Infection Nosocomial Infections.
Diplococcus Arrangement Note cocci in pairs (arrows).
Humans and the Microbial World Chapter 1. What is a Microorganism? 1.Definition 2.Prokaryotic or Eukaryotic? 3.Unicellular or Multicellular?
T HE P OLYMICROBIAL N ATURE OF O TITIS M EDIA I NFECTIONS Michael Dorrington Bowdish Lab.
Molecular characterisation of methicillin-sensitive Staphylococcus aureus from deep surgical site infections in orthopaedic patients.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
The Inflammasome: Critical Roles in Intestinal Homeostasis Hasan Zaki, PhD Department of Pathology UT Southwestern Medical Center.
ESI workshop Stochastic Effects in Microbial Infection The National e-Science Centre Edinburgh September 28-29, 2010.
Infection and Disease Fungi Parasites Nosocomial infection Diagnosis of infectious disease.
Introduction. microorganism acellular microbe virus prokaryotic microbe eukaryotic microbe fungus.
Chapter 17 Host- Microbe Interaction Biology 261 Medgar Evers College, CUNY Prof. Santos.
Commensal and Pathogenic Microbial Flora in Humans
1 Host-Microbe Relationships and Disease Classical ecological definitions –Mutualism: organisms live together, both benefit E. coli in GI tract; we get.
Pathogenicity of Infectious Diseases. PATHOGENENVIRONMENT HOST DISEASE TRIAD Host-Parasite Interactions OTHER MICROBES Microbial Interactions.
Prokaryotic Diversity and Molecular Genetics Biol 103 Diversity of Life.
Pathogenesis of Infectious Diseases CLS 212: Medical Microbiology.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
Introduction to Microbiology & Handwashing
Biological Hazards Environmental Science Unit 7.2.
Microbes and disease Microbes and Disease: Establishing a Connection History and Relevance of Koch's Postulates And The Germ Theory of Infectious Disease.
Open Access Articles. About Iore Iore is an Open Access publisher with its centers located in UK USA and India, making authenticated and reliable contributions.
Microbial toxin There are several virulence factors which help to establish disease The virulence of some bacteria is thought to be aided by the production.
Probiotics and Prebiotics emerging roles in health Amin Salehi-Abargouei PhD in Nutrition Nutrition and Food Security research Center Shahid Sadoughi.
PowerPoint ® Lecture Presentations prepared by John Zamora Middle Tennessee State University C H A P T E R © 2015 Pearson Education, Inc. Microbial Interactions.
Recognition of, and interaction with, the gut microbiota
Pathogenesis of Infectious Diseases
PHC Expert Group ImPrim project kick-off in Karlskrona, Sweden, February Participation of some 15 full and associated partners from 7 countries including.
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Prof. Ramesh Wigneshweraraj
Harald Renz, MD, Patrick G. Holt, FAA, Michael Inouye, PhD, Alan C
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow  Melissa.
Microbial Influences in Inflammatory Bowel Diseases
Impact of JPIAMR funded projects: Strategy development
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
Immunity to Infectious Diseases
JPIAMR Joint Research Calls – Update and Future Calls
Role of the Microbiota in Immunity and Inflammation
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
The Impact of the Gut Microbiota on Human Health: An Integrative View
Kian Fan Chung, MD, DSc, FRCP 
M-H Pinard-van der Laan
Dissemination of Antibiotic Resistance
Presentation transcript:

MICROBES AND MAN Research Programme October 13, 2004 Berlin Soile Juuti Programme manager Finland

Funding agencies of MICMAN Academy of Finland The main governmental funding agency of basic science in Finland Annual research funding over 200 million € The Swedish Foundation for Strategic Research (SSF) Foundation based on governmental funding Annual reserach funding ab. 60 million €

Budget: 5,4 million € 15 projects (26 research groups) 125 persons; 45 doctoral students A joint coordination MICMAN 3 Finland: 4.1 M€ Sweden: 1.3 M€ Finland: 21 groups Sweden: 5 groups

To increase the knowledge of the interaction between host and microbes To apply this knowledge to the maintenance of health and the prevention and treatment of diseases OBJECTIVES OF MICMAN Researcher training and exchange Multidisciplinary networks Internationality

SHARED ACTIVITIES ( + ) programme memorandum: general description of the aims and the themes call for applications evaluation of applications proposal of decisions final scientific evaluation (in 2006) coordination: programme activities - Funding agencies support groups on their own country only - Research reports according to slightly modified practicies

THEMES OF THE 15 PROJECTS THEMES OF THE 15 PROJECTS Resident microbiota - influence of internal and external factors Host-microbe interactions in the development and course of diseases 4 Other 2 9 Development and application of modern molecular biology methods

Host-microbe interactions in the development and course of diseases Molecular biology of infections e.g., Host-pathogen interaction of Streptococcus pyogenes (bacteriological, immunological and genetic studies) Immune evasion mechanisms and molecules of microbial pathogens (Borreliae, Streptococci

Resident microbiota Development, composition and health effects under the influence of host itself and environmental factors (pathogenic and probiotic bacteria) e.g., Long-term impact of antimicrobial treatment for the microbial flora of the gastrointestinal tract The role of probiotics in the development of the mucosal immune system in infancy

Species studied Borrelia Chlamydia pneumoniae Cyanobacteria Echinococcus granulosus Escherichia coli Helicobacter pylori Lactobacillus Salmonella Staphylococcus aureus Streptococcus Yersinia

MICMAN and Era-Net MICMAN will end 12/ however Continuation as a “virtual programme” We are ready and willing to collaborate regarding organizations of workshops, seminars, post-graduate courses, etc. Proposal for a graduate school ( ) under preparation  Annual Seminar of MICMAN: February 16-17, 2005 Helsinki, Finland ( >Events)

Allocation of funding to the transnational calls of Era-Net? (Academy of Finland, SSF?) MICMAN and Era-Net

Host-microbe interactions in the development and course of diseases MICMAN PROJECTS 1. Reactivation and immune evasion of Borrelia infection - Aim: interactions of Borrelia spirochetes and the host during infection (e.g. production of gene expression data in interaction with host) 2. Pathogenesis of reactive arthritis - Aim: mechanisms and molecules behind the incomplete eliminarion of bacteria causing reactive arthitis (Salmonella/Yersinia). 3. Microbes and allergy: From population observations to animal models - Aim: relative role of genes vs. environment in atopic diseases (H.pylori)

4. Microbial factors and host resposes discriminating commensals from pathogens - Aim: bacterial factors and mechanisms that cause the host to regulate its reactions to asymptomatic colonisers and pathogenic bacteria (Salmonella, Streptococcus, Lactobacillus) 5. A paradox of a microbe and man - what makes Staphylococcus aureus a pathogen? - Aim: to develop a system for the virulence gene expression studies in S.a. 6. Genetic susceptibility to streptococcal infections - Aim: to study e.g. molecular properties of various streptococcal strains MICMAN PROJECTS Host-microbe interactions in the development and course of diseases

MICMAN PROJECTS 7. Microbial resistance to innate immunity - Aim: immune evasion mechanisms of microbes; deficiencies that predispose to infections 8. Host-microbe interaction in acute and persistent Chlamydia pneumoniae infection - Aim: molecular mechanisms by which C.p. contributes to the pathogenesis of acute and persistent infections 9. Microbial pathogenesis of cardiovascular disease - Aim: ethiological role of Chlamydia pneumoniae and other microbes and the host inflammatory response Host-microbe interactions in the development and course of diseases

MICMAN PROJECTS 10. Bacterial-epithelial cross-talk and the establishment of the mucosal immune system - Aim: role of bacterial-epithelial cell interactions for intestinal leukocyte populations 11. Microbial ecology of man in health and disease: Emergence, spread and persistence of antibiotic resistance in the normal microflora - Aim: e.g. to develop new molecular methods for analyses of normalflora 12.Host-microbe crosstalk in infancy: creating a balance between the internal and external environments - Aim: effects of probiotics on infants 13.DNA microarrays for studying interactions of probiotic, pathogenic and normal gut microbiota bacteria with human intestinal epithelial cells - Aim: gene expression patterns elicited in host intestinal cells by pathogenic, probiotic and normal intestainal bacteria Resident microflora

MICMAN PROJECTS 14. Infectious origins of the human genome. Human endogenous retroviruses in health and disease - Aim: Development of bioinformatics 15. Cyanobacteria and adjacent microbes: causes of acute human intoxications and indicators of water quality - Aim: acute intoxications associated with cyanobacteria; causative agents and mechanisms Other themes